Ticker Details
Embecta Corp.
IPO Date:	April 1, 2022
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$525.28M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 2.15%
Avg Daily Range (30 D):	$0.12 | 1.34%
Avg Daily Range (90 D):	$0.21 | 1.87%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	.64M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	59
Avg Trade Size (Sh.) (30 D):	59
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	1,525
Avg Institutional Trade:	$2.19M
Avg Institutional Trade (30 D):	$1.61M
Avg Institutional Trade (90 D):	$1.84M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.38M
Avg Closing Trade (30 D):	$1.66M
Avg Closing Trade (90 D):	$1.91M
Avg Closing Volume:	121.07K

News

Mar 19, 2026 @ 3:37 PM Embecta Rallies After UK Firm Deal Worth $200 Mill... Source: Vandana Singh

Mar 19, 2026 @ 10:30 AM embecta Announces Definitive Agreement to Acquire ... Source: Na

Feb 6, 2026 @ 8:15 PM 3 Healthcare Stocks Paying the Highest Dividends o... Source: Thomas Niel

Feb 5, 2026 @ 11:00 AM embecta Announces Quarterly Cash Dividend Source: Na

Jan 22, 2026 @ 10:00 PM embecta to Report Fiscal First Quarter Financial R... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.75	$.46	$1.64
Diluted EPS	$.74	$.44	$1.62
Revenue	$261.2M	$264M	$1.08B
Gross Profit	$161.7M	$158.5M	$676.8M
Net Income / Loss	$44.1M	$26.4M	$95.4M
Operating Income / Loss	$83.3M	$56.5M	$242.1M
Cost of Revenue	$99.5M	$105.5M	$403.6M
Net Cash Flow	$-24.9M	$-4.9M	$-44.3M
PE Ratio	12.09